Bicycle Therapeutics plc Stock Split Ratio
Bicycle Therapeutics plc (BCYC) reported Stock Split Ratio of 142.90% for the 1-month period ending 2019-05-31, per its 10-K filed 2022-03-01.
Discontinued › Notes
us-gaap:StockholdersEquityNoteStockSplitConversionRatio1 · last filed 2022-03-01
- 2019-05-31: Stockholders' Equity Note, Stock Split, Conversion Ratio 1 month 142.90%.
- 2019-05-09: Stockholders' Equity Note, Stock Split, Conversion Ratio 142.90%.
| Period end | Stockholders' Equity Note, Stock Split, Conversion Ratio | Stockholders' Equity Note, Stock Split, Conversion Ratio 1 month |
|---|---|---|
| 2019-05-31 | 142.90% 10-K · filed 2022-03-01 | |
| 2019-05-09 | 142.90% 10-Q · filed 2019-11-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Quantum Cyber N.V. (QUCY) | $0.113B | ||
| Immuneering Corp (IMRX) | United States | $0.113B | -12.51 |
| GENELUX Corp (GNLX) | United States | $0.110B | -3.83 |
| Equillium, Inc. (EQ) | United States | $0.109B | -11.27 |
| Biomea Fusion, Inc. (BMEA) | United States | $0.107B | -3.30 |
| Polaryx Therapeutics, Inc. (PLYX) | United States | $0.106B | |
| OnKure Therapeutics, Inc. (OKUR) | United States | $0.119B | -3.13 |
| Coya Therapeutics, Inc. (COYA) | United States | $0.121B | -6.35 |
| CUMBERLAND PHARMACEUTICALS INC (CPIX) | United States | $0.121B | -8.95 |
| ProMIS Neurosciences Inc. (PMN) | $0.102B |